An Open Label, Prospective, Study to Assess the Safety, Tolerability, Efficacy and Phamacokinetics of APL-2 in Patients with Warm Antibody Autoimmune Hemolytic Anemia (WAIHA) or Cold Agglutininin Disease (CAD)

Type of Cancer
Hematological Malignancies

Site
Bethesda

Protocol Number
APL2-CP-AIHA-208

To Learn More Call
(201)-510-0950